Fredun Pharmaceuticals Schedules Q2 and H1 FY27 Earnings Call on 16th Nov'26
Fredun Pharmaceuticals Ltd 路 Intimation 路 16 Nov 2026, 12:00 pm
Fredun Pharmaceuticals Schedules Q2 and H1 FY27 Earnings Call on 16th Nov'26 Fredun Pharmaceuticals Limited will host its Q2 and H1 FY27 earnings conference call on Monday, 16th Nov'26, at 12:00 PM. Managing Director Mr. Fredun Medhora will represent the management team to discuss the financial performance and operational updates. Investors can participate using the universal dial-in numbers +91 22 6280 1239 or +91 22 7115 8140, or via Diamond Pass pre-registration.
Original exchange filing (PDF)
More announcements from Fredun Pharmaceuticals Ltd
- Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited. 路 16 Nov 2026
- Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 路 14 Nov 2026
- Report of Monitoring Agency on the use of proceeds raised through Preferential Allotment for the quarters ended March 31, 2026, June 30,2026 and September30, 2026. 路 14 Nov 2026
- Statement of Deviation or Variation For the Quarter Ended September 30, 2026 for the Funds raised through Preferential Issue. 路 14 Nov 2026
- Press Release 路 06 Nov 2026
- Approval for National Stock Exchange of India Limited (NSE) Listing Application. 路 05 Nov 2026
- Financial results for the quarter ended 30th September, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting dated 05th November, 2026. 路 05 Nov 2026
